Kiniksa Pharma shares jumped on Wednesday after the firm announced that the FDA granted Breakthrough Therapy designation for rilonacept for the treatment of recurrent pericarditis.
Karuna Therapeutics shares skyrocketed on Monday after the firm announced mid-stage results from its schizophrenia treatment. Now shares are on the move again after Karuna said that it would be conducting a secondary offering…
The unhealthiest state in the union, according to statistics compiled by LetsGetChecked, a home health and wellness testing site, is West Virginia. The healthiest state by the same metrics is Utah. Using data from…
On top of the potential game-changer for schizophrenia patients, some Karuna Therapeutics investors just experienced the same euphoria as holding a winning lottery ticket.
There is a huge risk-reward factor in emerging pharmaceutical and biotech companies that happen to have all their eggs in just one basket. That's the case of resTORbio.
In a new report on antibiotic-resistant germs, the CDC highlights the rising levels of risk and what we must do to control the risk of spreading these germs.
Tilray released its third quarter financial results after the closing bell on Tuesday. The company said that it had a net loss of $0.50 per share and $51.1 million in revenue, compared with consensus…
Solid Bio shares were absolutely crushed on Tuesday after the firm announced that the FDA has placed its Ignite DMD Phase 1/2 study of SGT-001 on hold.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in most of these…
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.